SPL-028

N/A

Report date: 2025/06/05 16:57:21

NME

Base Information

Drug NameSPL-028

Drug Alias NameSPL-028SPL-028i

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionSerotonin 2a (5-HT2a) receptor agonistsSigma opioid receptor agonists

TargetsSerotonin 2a (5-HT2a) receptorSigma opioid receptor

Therapy Area/IndicationsDepressive Disorder, Major

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited Kingdom

CombinationsNo

Global Highest StatusPhase 1 Clinical

Highest Status in ChinaN/A

Originator CompaniesSmall Pharma Ltd

China Registration ClassN/A

Inactive CompaniesN/A

Active IndicationsDepressive Disorder, Major

Inactive IndicationsN/A

ATC CodeN/A